Literature DB >> 15797514

MHC polymorphism: AIDS susceptibility in non-human primates.

Ronald E Bontrop1, David I Watkins.   

Abstract

One of the main host factors controlling resistance to disease appears to be the MHC. The recent poor results in HIV-1/AIDS Phase 3 vaccine field trials underline the importance of non-human primate models for AIDS. These models have been, and will continue to be, important for the definition of protective immune responses relevant to successful vaccine design because they supply essential information on the basic biology of lentivirus infections, mechanisms of resistance, escape and vaccine development.

Entities:  

Mesh:

Year:  2005        PMID: 15797514     DOI: 10.1016/j.it.2005.02.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  46 in total

1.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Neutrophil progenitor populations of rhesus macaques.

Authors:  Kim L Weisgrau; Logan J Vosler; Nicholas L Pomplun; Jennifer M Hayes; Heather A Simmons; Kristen R Friedrichs; Eva G Rakasz
Journal:  J Leukoc Biol       Date:  2018-11-05       Impact factor: 4.962

3.  Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius.

Authors:  Roger W Wiseman; Jason A Wojcechowskyj; Justin M Greene; Alex J Blasky; Tobias Gopon; Taeko Soma; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

5.  Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cells.

Authors:  Nami Iwamoto; Naofumi Takahashi; Sayuri Seki; Takushi Nomura; Hiroyuki Yamamoto; Makoto Inoue; Tsugumine Shu; Taeko K Naruse; Akinori Kimura; Tetsuro Matano
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

6.  Immunogenetic characterization of a captive colony of sooty mangabeys (Cercocebus atys) used for SIV research.

Authors:  Geary R Smith; Liesel Bauer; Maria M Crane; Zachary P Johnson
Journal:  J Med Primatol       Date:  2015-01-21       Impact factor: 0.667

Review 7.  Haplessly hoping: macaque major histocompatibility complex made easy.

Authors:  Roger W Wiseman; Julie A Karl; Patrick S Bohn; Francesca A Nimityongskul; Gabriel J Starrett; David H O'Connor
Journal:  ILAR J       Date:  2013

8.  Identification of MHC class I sequences in four species of Macaca of China.

Authors:  Xiang Yan; Aixue Li; Lin Zeng; Yuhua Cao; Jianbin He; Longbao Lv; Lihua Sui; Huahu Ye; Junwen Fan; Xiaoxia Cui; Zhaozeng Sun
Journal:  Immunogenetics       Date:  2013-09-18       Impact factor: 2.846

9.  Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.

Authors:  Jason A Wojcechowskyj; Levi J Yant; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques.

Authors:  Patricia Polacino; Kay Larsen; Lindsey Galmin; John Suschak; Zane Kraft; Leonidas Stamatatos; David Anderson; Susan W Barnett; Ranajit Pal; Kristen Bost; A H Bandivdekar; Christopher J Miller; Shiu-Lok Hu
Journal:  J Med Primatol       Date:  2008-12       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.